Jacob Jelsing

6.4k total citations · 1 hit paper
102 papers, 4.9k citations indexed

About

Jacob Jelsing is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Jacob Jelsing has authored 102 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 33 papers in Surgery and 31 papers in Physiology. Recurrent topics in Jacob Jelsing's work include Diabetes Treatment and Management (29 papers), Regulation of Appetite and Obesity (24 papers) and Diet and metabolism studies (22 papers). Jacob Jelsing is often cited by papers focused on Diabetes Treatment and Management (29 papers), Regulation of Appetite and Obesity (24 papers) and Diet and metabolism studies (22 papers). Jacob Jelsing collaborates with scholars based in Denmark, United States and Germany. Jacob Jelsing's co-authors include Niels Vrang, Henrik H. Hansen, Lotte Bjerre Knudsen, Gitte Hansen, Louise S. Dalbøge, Nanna Marie Lind, Charles Pyke, Mads Tang‐Christensen, Kirsten Raun and Paul Cumming and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Jacob Jelsing

102 papers receiving 4.8k citations

Hit Papers

The arcuate nucleus mediates GLP-1 receptor agonist lirag... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Jelsing Denmark 38 1.8k 1.2k 1.2k 1.1k 878 102 4.9k
Robin L. Davisson United States 52 1.3k 0.7× 2.6k 2.1× 779 0.6× 1.9k 1.7× 337 0.4× 117 8.1k
Kevin D. Niswender United States 32 1.3k 0.7× 2.0k 1.6× 1.2k 1.0× 1.0k 0.9× 437 0.5× 97 4.6k
Andrew M. Allen Australia 52 1.4k 0.8× 2.4k 1.9× 855 0.7× 1.2k 1.1× 313 0.4× 145 7.6k
V. Schusdziarra Germany 38 796 0.4× 1.2k 1.0× 2.3k 1.9× 1.2k 1.1× 1.4k 1.6× 182 6.0k
Jonathan B. Jaspan United States 40 1.7k 0.9× 1.1k 0.9× 1.3k 1.1× 1.6k 1.5× 944 1.1× 91 5.4k
Kirsten Raun Denmark 29 1.2k 0.7× 995 0.8× 620 0.5× 818 0.7× 379 0.4× 84 3.2k
Min‐Seon Kim South Korea 40 755 0.4× 1.5k 1.2× 709 0.6× 1.9k 1.7× 978 1.1× 145 4.9k
Tony K.T. Lam Canada 45 1.5k 0.8× 2.3k 1.9× 2.1k 1.7× 3.4k 3.1× 1.0k 1.2× 105 7.2k
Roland N. Auer Canada 55 1.1k 0.6× 2.2k 1.8× 559 0.5× 1.1k 1.0× 1.0k 1.2× 146 8.5k
Christof Schöfl Germany 35 1.9k 1.1× 1.0k 0.8× 766 0.6× 584 0.5× 439 0.5× 119 3.9k

Countries citing papers authored by Jacob Jelsing

Since Specialization
Citations

This map shows the geographic impact of Jacob Jelsing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Jelsing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Jelsing more than expected).

Fields of papers citing papers by Jacob Jelsing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Jelsing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Jelsing. The network helps show where Jacob Jelsing may publish in the future.

Co-authorship network of co-authors of Jacob Jelsing

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Jelsing. A scholar is included among the top collaborators of Jacob Jelsing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Jelsing. Jacob Jelsing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madsen, Martin Rønn, Henrik H. Hansen, Merete Juhl Kønig, et al.. (2022). A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity. PLoS ONE. 17(10). e0275901–e0275901. 5 indexed citations
2.
Roostalu, Urmas, Henrik H. Hansen, Thomas A. Lutz, et al.. (2021). Whole‐brain mapping of amylin‐induced neuronal activity in receptor activity–modifying protein 1/3 knockout mice. European Journal of Neuroscience. 54(1). 4154–4166. 13 indexed citations
3.
Zhang, Chen, Henrik H. Hansen, Tina Jorsal, et al.. (2020). Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment. The Journal of Clinical Endocrinology & Metabolism. 106(2). e966–e981. 34 indexed citations
4.
Eid, John, Mikkel Christensen‐Dalsgaard, Morten Otto Alexander Sommer, et al.. (2020). Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db mice. Biomedicine & Pharmacotherapy. 133. 110966–110966. 12 indexed citations
5.
Østergaard, Mette V., Jacob Lercke Skytte, Urmas Roostalu, et al.. (2020). Automated Image Analyses of Glomerular Hypertrophy in a Mouse Model of Diabetic Nephropathy. Kidney360. 1(6). 469–479. 16 indexed citations
6.
Zhang, Chen, Lise Rudkjær, Thorsten Schmidt, et al.. (2020). Transcriptomic changes in pancreatic islets, adipose and liver after Roux-en-Y gastric bypass in a diet-induced obese rat model. Peptides. 136. 170467–170467. 1 indexed citations
7.
Veidal, Sanne Skovgård, Christina Christoffersen, Michael Feigh, et al.. (2019). Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH. BMC Gastroenterology. 19(1). 228–228. 12 indexed citations
8.
Holm, Jacob Bak, Albert Pallejá, Pernille Wismann, et al.. (2019). Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice. Scientific Reports. 9(1). 15582–15582. 84 indexed citations
9.
Barkholt, Pernille, Kristoffer Rigbolt, Thomas Hübschle, et al.. (2019). Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss. Scientific Reports. 9(1). 16161–16161. 10 indexed citations
10.
Tølbøl, K.S., Birgit Stierstorfer, Jörg F. Rippmann, et al.. (2018). Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences. 64(5). 1238–1256. 18 indexed citations
11.
Dalbøge, Louise S., Gitte Hansen, Søren Roi Midtgaard, et al.. (2017). GUB06‐046, a novel secretin/glucagon‐like peptide 1 co‐agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice. Journal of Peptide Science. 23(12). 845–854. 19 indexed citations
12.
Hansen, Henrik H., Pernille Barkholt, Katrine Fabricius, et al.. (2015). The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy. Brain Research. 1634. 158–170. 77 indexed citations
13.
Dalbøge, Louise S., Philip J. Pedersen, Gitte Hansen, et al.. (2015). A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents. PLoS ONE. 10(8). e0135634–e0135634. 39 indexed citations
14.
Hansen, Henrik H., Katrine Fabricius, Pernille Barkholt, et al.. (2015). The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 46(4). 877–888. 155 indexed citations
15.
Dalbøge, Louise S., Søren L. Pedersen, Thomas Secher, et al.. (2015). Neuromedin U inhibits food intake partly by inhibiting gastric emptying. Peptides. 69. 56–65. 16 indexed citations
16.
Hansen, Henrik H., Jacob Jelsing, Gitte Hansen, et al.. (2014). The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat. Journal of Pharmacology and Experimental Therapeutics. 350(3). 657–664. 51 indexed citations
17.
Dalbøge, Louise S., et al.. (2014). The Novel GLP-1–Gastrin Dual Agonist ZP3022 Improves Glucose Homeostasis and Increases β-Cell Mass without Affecting Islet Number in db/db Mice. Journal of Pharmacology and Experimental Therapeutics. 350(2). 353–360. 32 indexed citations
18.
Jelsing, Jacob, Philip J. Larsen, & Niels Vrang. (2009). The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion. Neuroscience Letters. 463(2). 125–129. 18 indexed citations
20.
Jelsing, Jacob, Anders Hay‐Schmidt, Tim B. Dyrby, et al.. (2006). The prefrontal cortex in the Göttingen minipig brain defined by neural projection criteria and cytoarchitecture. Brain Research Bulletin. 70(4-6). 322–336. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026